Search research articles
Contact Us
Filters
Showing results (41-50 of 184) with videos related to
Page
of 19
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2012
Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy
Sabine Stegmaier, Stefan S Bielack, Ivo Leuschner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 22, 2006
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project
C A Stiller, S S Bielack, G Jundt, et al.
Anticancer Research
|
July 1, 1995
Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance
S S Bielack, K Kallenbach, G Looft, et al.
Clinical Orthopaedics and Related Research
|
February 12, 1999
Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma
M Sluga, R Windhager, S Lang, et al.
Cancer Management and Research
|
December 9, 2021
Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
Stefanie Hecker-Nolting, Thorsten Langer, Claudia Blattmann, et al.
Nuklearmedizin. Nuclear Medicine
|
January 1, 2000
High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma
C Franzius, S Bielack, J Sciuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group
S S Bielack, B Kempf-Bielack, U Heise, et al.
Journal of Cancer Research and Clinical Oncology
|
March 26, 2004
High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature
B Leidinger, S Bielack, G Koehler, et al.
Bone Marrow Transplantation
|
July 4, 2001
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
A Sauerbrey, S Bielack, B Kempf-Bielack, et al.
Nuklearmedizin. Nuclear Medicine
|
January 19, 2002
High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma
C Franzius, S Bielack, S Flege, et al.
Page
of 19
Search research articles
Search
Showing results (41-50 of 184) with videos related to
Sort By:
Page
of 19
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 4, 2012
Questionable universal validity of PAX3/FOXO1 fusion gene status as molecular marker for improvement of risk stratification in rhabdomyosarcoma therapy
Sabine Stegmaier, Stefan S Bielack, Ivo Leuschner, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 22, 2006
Bone tumours in European children and adolescents, 1978-1997. Report from the Automated Childhood Cancer Information System project
C A Stiller, S S Bielack, G Jundt, et al.
Anticancer Research
|
July 1, 1995
Structurally modified anthracyclines retain activity in a cell line with simultaneous typical and atypical multidrug resistance
S S Bielack, K Kallenbach, G Looft, et al.
Clinical Orthopaedics and Related Research
|
February 12, 1999
Local and systemic control after ablative and limb sparing surgery in patients with osteosarcoma
M Sluga, R Windhager, S Lang, et al.
Cancer Management and Research
|
December 9, 2021
Current Insights into the Management of Late Chemotherapy Toxicities in Pediatric Osteosarcoma Patients
Stefanie Hecker-Nolting, Thorsten Langer, Claudia Blattmann, et al.
Nuklearmedizin. Nuclear Medicine
|
January 1, 2000
High-activity samarium-153-EDTMP therapy in unresectable osteosarcoma
C Franzius, S Bielack, J Sciuk, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 24, 1999
Combined modality treatment for osteosarcoma occurring as a second malignant disease. Cooperative German-Austrian-Swiss Osteosarcoma Study Group
S S Bielack, B Kempf-Bielack, U Heise, et al.
Journal of Cancer Research and Clinical Oncology
|
March 26, 2004
High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature
B Leidinger, S Bielack, G Koehler, et al.
Bone Marrow Transplantation
|
July 4, 2001
High-dose chemotherapy (HDC) and autologous hematopoietic stem cell transplantation (ASCT) as salvage therapy for relapsed osteosarcoma
A Sauerbrey, S Bielack, B Kempf-Bielack, et al.
Nuklearmedizin. Nuclear Medicine
|
January 19, 2002
High-activity samarium-153-EDTMP therapy followed by autologous peripheral blood stem cell support in unresectable osteosarcoma
C Franzius, S Bielack, S Flege, et al.
Page
of 19